AbbVie Price to Free Cash Flow Ratio 2010-2019 | ABBV

Historical price to free cash flow ratio values for AbbVie (ABBV) since 2010.
AbbVie Price to Free Cash Flow Ratio Historical Data
Date Stock Price TTM FCF per Share Price to FCF Ratio
2019-09-20 72.39 3.61
2019-06-30 72.72 $20.06 3.62
2019-03-31 80.59 $19.88 4.05
2018-12-31 91.04 $19.50 4.67
2018-09-30 92.42 $17.11 5.40
2018-06-30 89.64 $15.21 5.89
2018-03-31 90.63 $14.28 6.35
2017-12-31 91.94 $13.95 6.59
2017-09-30 83.89 $12.09 6.94
2017-06-30 67.85 $10.83 6.26
2017-03-31 60.37 $10.73 5.63
2016-12-31 57.42 $10.71 5.36
2016-09-30 57.30 $10.97 5.22
2016-06-30 55.75 $10.95 5.09
2016-03-31 50.95 $10.56 4.82
2015-12-31 52.26 $10.22 5.11
2015-09-30 47.54 $7.77 6.12
2015-06-30 58.28 $6.93 8.41
2015-03-31 50.36 $6.28 8.02
2014-12-31 55.87 $5.69 9.82
2014-09-30 48.94 $7.46 6.56
2014-06-30 47.45 $8.10 5.86
2014-03-31 42.83 $8.70 4.93
2013-12-31 43.65 $9.08 4.81
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $105.963B $32.753B
AbbVie is a global, research-based biopharmaceutical company. AbbVie combines the focus and passion of a leading-edge biotech with the expertise and structure of a long-established pharmaceutical leader. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. AbbVie aims to help patients' live healthier lives and collaborate on sustainable healthcare solutions.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $343.382B 14.95
Roche Holding AG (RHHBY) Switzerland $244.080B 0.00
Merck (MRK) United States $214.995B 17.68
Pfizer (PFE) United States $201.939B 11.89
Novartis AG (NVS) Switzerland $197.897B 17.03
Novo Nordisk (NVO) Denmark $122.852B 21.71
AstraZeneca (AZN) United Kingdom $117.046B 22.65
Sanofi (SNY) France $112.486B 13.82
Eli Lilly (LLY) United States $110.397B 20.60
GlaxoSmithKline (GSK) United Kingdom $103.061B 12.95
Bristol-Myers Squibb (BMY) United States $81.903B 11.62
Bayer (BAYRY) Germany $68.710B 10.01
H Lundbeck (HLUYY) Denmark $6.906B 9.97